Multiple sclerosis tertiary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


==Tertiary Prevention==
==Tertiary Prevention==
The [[drugs]] which are used to treat [[MS]] can reduce the progression of the [[disease]] and delay [[disability]] occurrence but cannot stop the [[disease]]. Finally [[Disability|disabilities]] appear so controlling them can be beneficial in increasing [[MS]] [[patients]]’ [[quality of life]].<ref name="pmid16168933">{{cite journal |author=Kesselring J, Beer S |title=Symptomatic therapy and neurorehabilitation in multiple sclerosis |journal=Lancet neurology |volume=4 |issue=10 |pages=643–52 |year=2005 |pmid=16168933|doi=10.1016/S1474-4422(05)70193-9}}</ref> There is strong evidence that [[exercise]] therapy can improve [[muscle]] function and [[mobility]] in multiple sclerosis patients.
The [[drugs]] which are used to treat [[MS]] can reduce the progression of the [[disease]] and delay [[disability]] occurrence but cannot stop the [[disease]]. Finally [[Disability|disabilities]] appear so controlling them can be beneficial in increasing [[MS]] [[patients]]’ [[quality of life]].<ref name="pmid16168933">{{cite journal |author=Kesselring J, Beer S |title=Symptomatic therapy and neurorehabilitation in multiple sclerosis |journal=Lancet neurology |volume=4 |issue=10 |pages=643–52 |year=2005 |pmid=16168933|doi=10.1016/S1474-4422(05)70193-9}}</ref> There is strong evidence that [[exercise]] therapy can improve [[muscle]] function and [[mobility]] in multiple sclerosis patients.<ref name="pmid15674920">{{cite journal |vauthors=Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G |title=Exercise therapy for multiple sclerosis |journal=Cochrane Database Syst Rev |volume= |issue=1 |pages=CD003980 |date=January 2005 |pmid=15674920 |doi=10.1002/14651858.CD003980.pub2 |url=}}</ref>
===Spasticity===
===Spasticity===
There are also [[palliative]] measures like [[casting]]s, [[splint (medical)|splints]] or customised seatings.<ref name="isbn = 1 86016 182 0">{{cite book | last = The Royal College of Physicians |title = Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care | publisher = Sarum ColourView Group | date = 2004 | location = Salisbury, Wiltshire |  isbn = 1 86016 182 0}}[http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf Free full text] ([[2004-08-13]]). Retrieved on [[2007-10-01]].</ref>
There are also [[palliative]] measures like [[casting]]s, [[splint (medical)|splints]] or customised seatings.<ref name="isbn = 1 86016 182 0">{{cite book | last = The Royal College of Physicians |title = Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care | publisher = Sarum ColourView Group | date = 2004 | location = Salisbury, Wiltshire |  isbn = 1 86016 182 0}}[http://www.rcplondon.ac.uk/pubs/books/MS/MSfulldocument.pdf Free full text] ([[2004-08-13]]). Retrieved on [[2007-10-01]].</ref>

Revision as of 18:15, 4 March 2018

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis tertiary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis tertiary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis tertiary prevention

CDC on Multiple sclerosis tertiary prevention

Multiple sclerosis tertiary prevention in the news

Blogs on Multiple sclerosis tertiary prevention

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis tertiary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tertiary Prevention

The drugs which are used to treat MS can reduce the progression of the disease and delay disability occurrence but cannot stop the disease. Finally disabilities appear so controlling them can be beneficial in increasing MS patientsquality of life.[1] There is strong evidence that exercise therapy can improve muscle function and mobility in multiple sclerosis patients.[2]

Spasticity

There are also palliative measures like castings, splints or customised seatings.[3]

Tremors and Ataxia

Physical therapy is not indicated as a treatment for tremor or ataxia; however, the use of different orthese devices can help. An example is the use of wrist bandages with weights, which can be useful to increase the inertia of movement and therefore reduce tremor.[4] Daily use objects have also to be adapted so they are easier to grab and use.

References

  1. Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". Lancet neurology. 4 (10): 643–52. doi:10.1016/S1474-4422(05)70193-9. PMID 16168933.
  2. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G (January 2005). "Exercise therapy for multiple sclerosis". Cochrane Database Syst Rev (1): CD003980. doi:10.1002/14651858.CD003980.pub2. PMID 15674920.
  3. The Royal College of Physicians (2004). Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care. Salisbury, Wiltshire: Sarum ColourView Group. ISBN 1 86016 182 0.Free full text (2004-08-13). Retrieved on 2007-10-01.
  4. Aisen ML, Arnold A, Baiges I, Maxwell S, Rosen M (1993). "The effect of mechanical damping loads on disabling action tremor". Neurology. 43 (7): 1346–50. PMID 8327136.

Template:WH Template:WS